NFKB2 and pancreatic ductal adenocarcinoma: NFKB2 has been observed to be upregulated in gastric cancer tissues (Rossi et al., 2019), and its altered expression can collaborate with heterozygous KrasMUT to drive tumorigenesis but decreases the metastatic potential of pancreatic ductal adenocarcinoma (Mueller et al., 2018).